Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(14%)
Results Posted
40%(2 trials)

Phase Distribution

Ph not_applicable
6
86%
Ph phase_3
1
14%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (14.3%)
N/A6 (85.7%)

Trials by Status

completed571%
recruiting114%
withdrawn114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7